1. Merck and Sanofi both buying smaller cancer oncology companies at big premiums — The latest from ASH2019 conference — Biopharma Dive’s drug launch of the year: Zolgensma — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Amgen IT


Sort By:
Title ↓
Replies Views
Last Message
  1. Anonymous
    Replies:
    9
    Views:
    5,436
  2. Anonymous
    Replies:
    1
    Views:
    3,554
  3. Anonymous
    Replies:
    1
    Views:
    2,554
  4. anonymous
    Replies:
    0
    Views:
    2,761
  5. Anonymous
    Replies:
    1
    Views:
    2,194
  6. Anonymous
    Replies:
    23
    Views:
    10,455
  7. quickann
    Replies:
    0
    Views:
    2,385
  8. Anonymous
    Replies:
    18
    Views:
    11,416
  9. Anonymous
    Replies:
    0
    Views:
    3,036
  10. anonymous
    Replies:
    3
    Views:
    807
  11. Anonymous
    Replies:
    0
    Views:
    2,996
  12. Krunk Crush
    Replies:
    8
    Views:
    4,533
  13. Anonymous
    Replies:
    8
    Views:
    5,675
  14. anonymous
    Replies:
    0
    Views:
    2,868
  15. Bill Gates
    Replies:
    1
    Views:
    4,498
  16. Anonymous
    Replies:
    0
    Views:
    3,227
  17. Anonymous
    Replies:
    4
    Views:
    5,699
  18. Anonymous
    Replies:
    4
    Views:
    3,137
  19. anonymous
    Replies:
    12
    Views:
    3,745
  20. naresh
    Replies:
    0
    Views:
    2,448

Thread Display Options

Loading...